Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

(2016) Ju-Hee Kang et al.   ACTA NEUROPATHOLOGICA

Patterns of cortical thinning in nondemented Parkinson's disease patients

(2016) Carme Uribe et al.   MOVEMENT DISORDERS

Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI)

(2015) Mike A. Nalls et al.   MOVEMENT DISORDERS

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits

(2015) Norbert Schuff et al.   MOVEMENT DISORDERS

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

(2015) Daniel Weintraub et al.   MOVEMENT DISORDERS

Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?

(2015) Gordon W. Duncan et al.   MOVEMENT DISORDERS

BDNF polymorphism associates with decline in set shifting in Parkinson's disease

(2015) Nicolien M. van der Kolk et al.   NEUROBIOLOGY OF AGING

Longitudinal study of normal cognition in Parkinson disease

(2015) Kara Pigott et al.   NEUROLOGY

Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects

(2015) Nicolaas I. Bohnen et al.   JAMA Neurology

Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study

(2013) A. J. Yarnall et al.   NEUROLOGY

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

(2012) Peder Buchhave   ARCHIVES OF GENERAL PSYCHIATRY

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease

(2012) Bernard Ravina et al.   MOVEMENT DISORDERS

Genetic influences on cognitive decline in Parkinson's disease

(2012) James F. Morley et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Within-subject template estimation for unbiased longitudinal image analysis

(2012) Martin Reuter et al.   NEUROIMAGE

FreeSurfer

(2012) Bruce Fischl   NEUROIMAGE

APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies

(2012) Debby Tsuang et al.   JAMA Neurology

Dementia Risk in Parkinson Disease

(2011) Núria Setó-Salvia et al.   ARCHIVES OF NEUROLOGY

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

(2011) D. Weintraub et al.   BRAIN

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

Parkinson's disease: The quintessential neuropsychiatric disorder

(2011) Daniel Weintraub et al.   MOVEMENT DISORDERS

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment

(2010) Charles H. Adler et al.   ACTA NEUROPATHOLOGICA

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

The MoCA: Well-suited screen for cognitive impairment in Parkinson disease

(2010) J. C. Dalrymple-Alford et al.   NEUROLOGY

Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis

(2010) D. Aarsland et al.   NEUROLOGY

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

White Matter Involvement in Idiopathic Parkinson Disease: A Diffusion Tensor Imaging Study

(2009) G. Gattellaro et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: Application to normal elderly and Alzheimer's disease participants

(2009) Kenichi Oishi et al.   NEUROIMAGE

Cholinergic denervation occurs early in Parkinson disease

(2009) N. I. Bohnen et al.   NEUROLOGY

Attentional control in Parkinson's disease is dependent on COMT val158met genotype

(2008) C. H. Williams-Gray et al.   BRAIN

Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study

(2008) D. Aarsland et al.   NEUROLOGY